#144: zantriocom: Zantrio.com Stock Picks for September 8, 2009
(BIIB) - shortBiogen Idec made an unsolicited, $356 million bid to buy Facet... |
September 8, 2009
08:30:12 AM |
#143: TheMachine: BIIB Stock News : Subset Data from Two Randomized Phase 3 Trials Show TYSABRI® Significantly Improves Health-Related Quality of Life for Crohn’s Disease Patients with Prior Exposure or Inadequate Response to Anti-TNFα Therapy
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) shared
... |
May 31, 2009
03:24:08 PM |
#142: zantriocom: Zantrio.com Stock Picks for April 17, 2009
(BIIB) - shortBiogen Idec said its Q1 earnings rose but, overall revenue and sales... |
April 17, 2009
08:34:44 AM |
#141: TheMachine: TYSABRI(R) Demonstrates Sustained Improvement in Functional Outcomes in Multiple Sclerosis Patients According to New Post-Hoc Analysis
-- TYSABRI is the Only Marketed MS Treatment to Show
Both... |
September 20, 2008
01:07:55 AM |
#140: TheMachine: Biogen Idec and Elan Will Host a Conference Call For the Investment Community
Biogen Idec Inc.(NASDAQ: BIIB) and Elan (NYSE: ELN) today announced it... |
August 7, 2008
07:29:39 AM |
#139: FastFun: Biogen Idec Completes Review of Strategic Alternatives
Company to Remain Independent
The Board of Directors of Biogen Idec... |
December 13, 2007
01:01:33 PM |
#138: Stock News Bot: Biogen Idec Completes Review of Strategic Alternatives
Biogen Idec Completes Review of Strategic Alternatives
Company to Remain... |
December 13, 2007
10:13:40 AM |
#137: FastFun: Biogen Idec Issues Statement
Biogen Idec Inc. (NASDAQ: BIIB) today announced that its Board of... |
October 17, 2007
11:47:57 PM |
#136: FastFun: Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
- Phase 2 monotherapy trial to be initiated by end of 2007 -
PRAGUE,... |
October 17, 2007
11:47:06 PM |
#135: Jason: BIIB, Jacobs Receives Contract From Biogen Idec for Biotechnology Project in Denmark
Jacobs Engineering Group Inc. (NYSE: JEC) announced today that they received a... |
May 18, 2007
09:12:37 PM |
#134: Stock News Bot: BIIB News Biogen Idec To Report First Quarter 2007 Financial Results on May 2, 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today announced... |
April 2, 2007
11:44:00 AM |
#133: Stock News Bot: BIIB News Biogen Idec to Present at the Cowen & Company 27th Annual Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today... |
March 6, 2007
02:03:00 PM |
#132: Stock News Bot: BIIB News Biogen Idec Reports Full Year and Fourth Quarter 2006 Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB), a global... |
February 15, 2007
04:39:00 AM |
#131: Stock News Bot: BIIB News Biogen Idec Announces Webcast of Presentation at the Wachovia Securities 2007 Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today... |
January 23, 2007
08:45:00 AM |
#130: Stock News Bot: BIIB News Biogen Idec To Report Fourth Quarter 2006 Financial Results on February 15, 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today announced... |
January 17, 2007
07:07:00 AM |
